Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation.
Ontology highlight
ABSTRACT: Coxsackievirus B1 (CVB1) is a leading causative agent of severe infectious diseases in humans and has been reported to be associated with outbreaks of aseptic meningitis, myocarditis, and the development of chronic diseases such as type 1 diabetes mellitus (T1DM). There is no approved vaccine or effective antiviral therapy to treat CBV1 infection. And animal models to assess the effects of antiviral agents and vaccine remain limited. In this study, we established a neonatal mouse model of CVB1 using a clinically isolated strain to characterize the pathological manifestations of virus infection and to promote the development of vaccines and antiviral drugs against CVB1. One-day-old BALB/c mice were susceptible to CVB1 infection by intraperitoneal injection. Mice challenged with CVB1 at a lo
SUBMITTER: Yin Z
PROVIDER: S-EPMC8476979 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA